Artimplant’s business model and future revenue flows are based on the exploitation and development of the patented biomaterial platform Artelon^®, from which implants in different clinical areas are being developed.

Product development, production, clinical studies, central marketing documentation and sales training are handled by Artimplant.

Sales and local marketing take place through the following channels:

• Global/regional license agreements, at present Small Bone Innovations
• Global OEM agreements (private label), at present Biomet Sports Medicine
• Regional or local distribution agreements
• Direct sales through Artimplant´s own sales team and agents